BRANCATO, VIRGINIA

BRANCATO, VIRGINIA  

DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE  

Mostra records
Risultati 1 - 20 di 43 (tempo di esecuzione: 0.019 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 02 - Intervento a convegno 2025 Zerbato, BBrancato, VTaglietti, LBarabino, SLa Ferla, BChiaradonna, F. +
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 02 - Intervento a convegno 2025 Zerbato, BBrancato, VTaglietti, LBarabino, SLa Ferla, BChiaradonna, F. +
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 02 - Intervento a convegno 2025 Zerbato, BBrancato, VTaglietti, LBarabino, SLa Ferla, BChiaradonna, F. +
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 02 - Intervento a convegno 2025 Zerbato, BBrancato, VTaglietti, LBarabino, SLa Ferla, BChiaradonna, F. +
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 02 - Intervento a convegno 2024 Zerbato, BBrancato, VChiaradonna, F. +
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 02 - Intervento a convegno 2024 Zerbato, BBrancato, VChiaradonna, F +
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 02 - Intervento a convegno 2024 Zerbato, BGobbi, MBrancato, VBrambilla, LChiaradonna, F. +
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 02 - Intervento a convegno 2024 Zerbato, BBrancato, VChiaradonna, F. +
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 02 - Intervento a convegno 2024 Zerbato, BBrancato, VChiaradonna, F. +
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 02 - Intervento a convegno 2024 Zerbato, BBrancato, VChiaradonna, F. +
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 02 - Intervento a convegno 2024 Zerbato, BBrancato, VGobbi, MChiaradonna, F. +
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 02 - Intervento a convegno 2024 Zerbato, BBrancato, VGobbi, MChiaradonna, F. +
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 02 - Intervento a convegno 2024 Zerbato, BBrancato, VGobbi, MChiaradonna, F. +
Chitosan-Based Biomaterials: Insights into Chemistry, Properties, Devices, and Their Biomedical Applications 01 - Articolo su rivista 2023 Petroni S.Tagliaro I.Antonini C.D’Arienzo M.Orsini S. F.Brancato V.Cipolla L. +
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 02 - Intervento a convegno 2023 Zerbato, BBrancato, VChiaradonna, F +
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 02 - Intervento a convegno 2023 Zerbato, BBrancato, VChiaradonna, F. +
Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model 01 - Articolo su rivista 2023 Brancato, V +
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 02 - Intervento a convegno 2023 Zerbato, BBrancato, VChiaradonna, F. +
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 02 - Intervento a convegno 2023 Zerbato, BBrancato, VChiaradonna, F. +
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 01 - Articolo su rivista 2023 Zerbato B.Brancato V.Pessina A.Brambilla L.Chiaradonna F. +